LIVIVO - Search results -

Search results

Result 1 - 10 of total 24

Search options

Article ; Online: A new emerging zoonotic virus of concern

José Millán-Oñate

Infectio, Vol 24, Iss 3, Pp 187-

the 2019 novel Coronavirus (SARS CoV-2)

2020 Volume 192

Abstract: Revisamos aquí el origen, características del brote y la epidemiología del nuevo Coronavirus (2019nCoV) responsable de una nueva enfermedad por coronavirus (COVID-19). Una rápida respuesta de las autoridades de salud mundiales está en marcha y se ha ... ...

Abstract	Revisamos aquí el origen, características del brote y la epidemiología del nuevo Coronavirus (2019nCoV) responsable de una nueva enfermedad por coronavirus (COVID-19). Una rápida respuesta de las autoridades de salud mundiales está en marcha y se ha hecho un llamado urgente para colaboración científica internacional. Las lecciones aprendidas de brotes previos con agentes virales similares han aumentado las capacidades para contener y controlar estas amenazas recurrentes a la salud global.
Keywords	coronavirus ; epidemias ; zoonosis ; viajeros ; colombia ; Therapeutics. Pharmacology ; RM1-950 ; Infectious and parasitic diseases ; RC109-216 ; covid19
Language	English
Publishing date	2020-04-01T00:00:00Z
Publisher	Asociación Colombiana de Infectología
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Successful recovery of COVID-19 pneumonia in a patient from Colombia after receiving chloroquine and clarithromycin.

Millán-Oñate, José / Millan, William / Mendoza, Luis Alfonso / Sánchez, Carlos Guillermo / Fernandez-Suarez, Hugo / Bonilla-Aldana, D Katterine / Rodríguez-Morales, Alfonso J

Annals of clinical microbiology and antimicrobials

2020 Volume 19, Issue 1, Page(s) 16

Abstract: Background: COVID-19 pandemics is a challenge for public health and infectious diseases clinicians, especially for the therapeutical approach that is not yet adequately defined. Amid this situation, investigational agents are being used, including ... ...

Abstract	Background: COVID-19 pandemics is a challenge for public health and infectious diseases clinicians, especially for the therapeutical approach that is not yet adequately defined. Amid this situation, investigational agents are being used, including chloroquine. We report here the clinical features and therapeutic course of the first reported patient with confirmed COVID-19 pneumonia that recovered in Colombia, after the use of chloroquine and clarithromycin. Case presentation: A 34-year-old male, returning from Spain, presented with complaints of fever, and cough, and class-II obesity, being hospitalized. The respiratory viruses and bacteria tested by FilmArray Conclusions: Our patient improved significantly. This and other COVID-19 cases are urgently demanding results from clinical trials that support evidence-based therapeutical approaches to this pandemic and the clinical management of patients, especially those at critical care.
MeSH term(s)	Adult ; Betacoronavirus ; Chloroquine/therapeutic use ; Clarithromycin/therapeutic use ; Colombia ; Coronavirus Infections/diagnosis ; Coronavirus Infections/drug therapy ; Humans ; Male ; Pandemics ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/drug therapy
Chemical Substances	Chloroquine (886U3H6UFF) ; Clarithromycin (H1250JIK0A)
Keywords	covid19
Language	English
Publishing date	2020-04-24
Publishing country	England
Document type	Case Reports ; Journal Article
ZDB-ID	2097873-X
ISSN	1476-0711 ; 1476-0711
ISSN (online)	1476-0711
ISSN	1476-0711
DOI	10.1186/s12941-020-00358-y
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Article: COVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugs.

Rodriguez-Morales, Alfonso J / Sah, Ranjit / Millan-Oñate, Jose / Gonzalez, Angel / Montenegro-Idrogo, Juan J / Scherger, Sias / Franco-Paredes, Carlos / Henao-Martínez, Andrés F

Therapeutic advances in infectious disease

2021 Volume 8, Page(s) 20499361211027065

Language	English
Publishing date	2021-06-18
Publishing country	England
Document type	Editorial
ZDB-ID	2728410-4
ISSN	2049-937X ; 2049-9361
ISSN (online)	2049-937X
ISSN	2049-9361
DOI	10.1177/20499361211027065
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Successful recovery of COVID-19 pneumonia in a patient from Colombia after receiving chloroquine and clarithromycin

Millán-Oñate, José / Millan, William / Mendoza, Luis Alfonso / Sánchez, Carlos Guillermo / Fernandez-Suarez, Hugo / Bonilla-Aldana, D. Katterine / Rodríguez-Morales, Alfonso J.

Annals of Clinical Microbiology and Antimicrobials

2020 Volume 19, Issue 1

Keywords	Microbiology (medical) ; Infectious Diseases ; General Medicine ; covid19
Language	English
Publisher	Springer Science and Business Media LLC
Publishing country	us
Document type	Article ; Online
ZDB-ID	2097873-X
ISSN	1476-0711
ISSN	1476-0711
DOI	10.1186/s12941-020-00358-y
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Order via subito

Details ▾
- Full text online
- Order with fees

Article: Successful recovery of COVID-19 pneumonia in a patient from Colombia after receiving chloroquine and clarithromycin

Millán-Oñate, José / Millan, William / Mendoza, Luis Alfonso / Sánchez, Carlos Guillermo / Fernandez-Suarez, Hugo / Bonilla-Aldana, D Katterine / Rodríguez-Morales, Alfonso J

Ann Clin Microbiol Antimicrob

Abstract: BACKGROUND: COVID-19 pandemics is a challenge for public health and infectious diseases clinicians, especially for the therapeutical approach that is not yet adequately defined. Amid this situation, investigational agents are being used, including ... ...

Abstract	BACKGROUND: COVID-19 pandemics is a challenge for public health and infectious diseases clinicians, especially for the therapeutical approach that is not yet adequately defined. Amid this situation, investigational agents are being used, including chloroquine. We report here the clinical features and therapeutic course of the first reported patient with confirmed COVID-19 pneumonia that recovered in Colombia, after the use of chloroquine and clarithromycin. CASE PRESENTATION: A 34-year-old male, returning from Spain, presented with complaints of fever, and cough, and class-II obesity, being hospitalized. The respiratory viruses and bacteria tested by FilmArray® PCR were negative. Two days later, clarithromycin was started because the patient was suspected as community-acquired pneumonia. At the third day, the rRT-PCR confirmed the SARS-CoV-2 infection. A day later, chloroquine was started because of that. His chest computed tomography was performed and showed bilateral multifocal ground-glass opacities with consolidation, which suggested viral pneumonia as a differential diagnosis. Progressively his clinical condition improved and at day 9, patient rRT-PCR for SARS-CoV-2 became negative. The patient was discharged and isolated at home per 14 days. CONCLUSIONS: Our patient improved significantly. This and other COVID-19 cases are urgently demanding results from clinical trials that support evidence-based therapeutical approaches to this pandemic and the clinical management of patients, especially those at critical care.
Keywords	covid19
Publisher	WHO
Document type	Article
Note	WHO #Covidence: #116464
Database	COVID19

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Details ▾

Article ; Online: Successful recovery of COVID-19 pneumonia in a patient from Colombia after receiving chloroquine and clarithromycin

Millán-Oñate, José / Millan, William / Mendoza, Luis Alfonso / Sánchez, Carlos Guillermo / Fernandez-Suarez, Hugo / Bonilla-Aldana, D. Katterine / Rodríguez-Morales, Alfonso J.

Annals of clinical microbiology and antimicrobials, 19(1):16

2020

Abstract	BACKGROUND: COVID-19 pandemics is a challenge for public health and infectious diseases clinicians, especially for the therapeutical approach that is not yet adequately defined. Amid this situation, investigational agents are being used, including chloroquine. We report here the clinical features and therapeutic course of the first reported patient with confirmed COVID-19 pneumonia that recovered in Colombia, after the use of chloroquine and clarithromycin. CASE REPRESENTATION: A 34-year-old male, returning from Spain, presented with complaints of fever, and cough, and class-II obesity, being hospitalized. The respiratory viruses and bacteria tested by FilmArray® PCR were negative. Two days later, clarithromycin was started because the patient was suspected as community-acquired pneumonia. At the third day, the rRT-PCR confirmed the SARS-CoV-2 infection. A day later, chloroquine was started because of that. His chest computed tomography was performed and showed bilateral multifocal ground-glass opacities with consolidation, which suggested viral pneumonia as a differential diagnosis. Progressively his clinical condition improved and at day 9, patient rRT-PCR for SARS-CoV-2 became negative. The patient was discharged and isolated at home per 14 days. CONCLUSIONS: Our patient improved significantly. This and other COVID-19 cases are urgently demanding results from clinical trials that support evidence-based therapeutical approaches to this pandemic and the clinical management of patients, especially those at critical care.
Keywords	COVID-19 ; Chloroquine ; Coronavirus Disease 2019 ; Latin America ; Severe Acute Respiratory Syndrome Coronavirus 2 ; Colombia ; SARS-CoV-2 ; covid19
Language	English
Publishing country	de
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: A new emerging zoonotic virus of concern: The 2019 novel Coronavirus (COVID-19)/ Un nuevo virus zoonótico emergente de preocupación: El Coronavirus novel 2019

Millán-Oñate, José / Rodriguez-Morales, Alfonso J. / Camacho-Moreno, German / Mendoza-Ramírez, Henry / Rodríguez-Sabogal, Iván Arturo / Álvarez-Moreno, Carlos

Infectio

Abstract: We review here the origin, outbreak characteristics and main epidemiological features of the novel Coronavirus (2019nCoV) responsible of a new coronavirus disease (COVID-19). Rapid global health authorities’ responses are now in course and international ... ...

Abstract	We review here the origin, outbreak characteristics and main epidemiological features of the novel Coronavirus (2019nCoV) responsible of a new coronavirus disease (COVID-19). Rapid global health authorities’ responses are now in course and international scientific collaboration is urgently need. Previous outbreaks experiences with similar viral agents have increased the capacity to containment and control of these recurrent health menaces.
Keywords	covid19
Publisher	WHO
Document type	Article ; Online
Note	WHO #Covidence: #87973
DOI	10.22354/in.v24i3.848
Database	COVID19

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Details ▾

Article: A new emerging zoonotic virus of concern: the 2019 novel Coronavirus (SARS CoV-2)/ Un nuevo virus zoonótico emergente de preocupación: el Coronavirus novel 2019

Millán-Oñate, José / Rodriguez-Morales, Alfonso J. / Camacho-Moreno, German / Mendoza-Ramírez, Henry / Rodríguez-Sabogal, Iván Arturo / Álvarez-Moreno, Carlos

Infectio

Abstract: Abstract We review here the origin, outbreak characteristics and main epidemiological features of the novel Coronavirus (2019nCoV) responsible of a new coronavirus disease (COVID-19). Rapid global health authorities' responses are now in course and ... ...

Abstract	Abstract We review here the origin, outbreak characteristics and main epidemiological features of the novel Coronavirus (2019nCoV) responsible of a new coronavirus disease (COVID-19). Rapid global health authorities' responses are now in course and international scientific collaboration is urgently need. Previous outbreaks experiences with similar viral agents have increased the capacity to containment and control of these recurrent health menaces.
Keywords	covid19
Publisher	WHO
Document type	Article
Note	WHO #Covidence: #87973
Database	COVID19

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Details ▾

Article ; Online: Successful recovery of COVID-19 pneumonia in a patient from Colombia after receiving chloroquine and clarithromycin

José Millán-Oñate / William Millan / Luis Alfonso Mendoza / Carlos Guillermo Sánchez / Hugo Fernandez-Suarez / D. Katterine Bonilla-Aldana / Alfonso J. Rodríguez-Morales

Annals of Clinical Microbiology and Antimicrobials, Vol 19, Iss 1, Pp 1-

2020 Volume 9

Abstract: Abstract Background COVID-19 pandemics is a challenge for public health and infectious diseases clinicians, especially for the therapeutical approach that is not yet adequately defined. Amid this situation, investigational agents are being used, ... ...

Abstract	Abstract Background COVID-19 pandemics is a challenge for public health and infectious diseases clinicians, especially for the therapeutical approach that is not yet adequately defined. Amid this situation, investigational agents are being used, including chloroquine. We report here the clinical features and therapeutic course of the first reported patient with confirmed COVID-19 pneumonia that recovered in Colombia, after the use of chloroquine and clarithromycin. Case presentation A 34-year-old male, returning from Spain, presented with complaints of fever, and cough, and class-II obesity, being hospitalized. The respiratory viruses and bacteria tested by FilmArray® PCR were negative. Two days later, clarithromycin was started because the patient was suspected as community-acquired pneumonia. At the third day, the rRT-PCR confirmed the SARS-CoV-2 infection. A day later, chloroquine was started because of that. His chest computed tomography was performed and showed bilateral multifocal ground-glass opacities with consolidation, which suggested viral pneumonia as a differential diagnosis. Progressively his clinical condition improved and at day 9, patient rRT-PCR for SARS-CoV-2 became negative. The patient was discharged and isolated at home per 14 days. Conclusions Our patient improved significantly. This and other COVID-19 cases are urgently demanding results from clinical trials that support evidence-based therapeutical approaches to this pandemic and the clinical management of patients, especially those at critical care.
Keywords	Coronavirus Disease 2019 (COVID-19) ; Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) ; Chloroquine ; Colombia ; Latin America ; Therapeutics. Pharmacology ; RM1-950 ; Infectious and parasitic diseases ; RC109-216 ; Microbiology ; QR1-502 ; covid19
Subject code	610
Language	English
Publishing date	2020-04-01T00:00:00Z
Publisher	BMC
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Multinational prospective cohort study of incidence and risk factors for central line-associated bloodstream infections in ICUs of 8 Latin American countries.

Rosenthal, Victor Daniel / Jin, Zhilin / Valderrama-Beltran, Sandra Liliana / Gualtero, Sandra Milena / Linares, Claudia Yaneth / Aguirre-Avalos, Guadalupe / Mijangos-Méndez, Julio Cesar / Ibarra-Estrada, Miguel Ángel / Jiménez-Alvarez, Luisa Fernanda / Reyes, Lidia Patricia / Alvarez-Moreno, Carlos Arturo / Zuniga-Chavarria, Maria Adelia / Quesada-Mora, Ana Marcela / Gomez, Katherine / Alarcon, Johana / Millan-Oñate, Jose / Aguilar-de-Moros, Daisy / Castaño-Guerrero, Elizabeth / Córdoba, Judith /

Sassoe-Gonzalez, Alejandro / Millán-Castillo, Claudia Marisol / Leyva-Xotlanihua, Lissette / Aguilar-Moreno, Lina Alejandra / Bravo-Ojeda, Juan Sebastian / Gutierrez-Tobar, Ivan Felipe / Aleman-Bocanegra, Mary Cruz / Echazarreta-Martínez, Clara Veronica / Flores-Sánchez, Belinda Mireya / Cano-Medina, Yuliana Andrea / Chapeta-Parada, Edwin Giovannny / Gonzalez-Niño, Rafael Antonio / Villegas-Mota, Maria Isabel / Montoya-Malváez, Mildred / Cortés-Vázquez, Miguel Ángel / Medeiros, Eduardo Alexandrino / Fram, Dayana / Vieira-Escudero, Daniela / Dueñas, Lourdes / Carreazo, Nilton Yhuri / Salgado, Estuardo / Yin, Ruijie

American journal of infection control

2023 Volume 51, Issue 10, Page(s) 1114–1119

Abstract: Background: Our objective was to identify central line (CL)-associated bloodstream infections (CLABSI) rates and risk factors in Latin-America.: Methods: From January 1, 2014 to February 10, 2022, we conducted a multinational multicenter prospective ... ...

Abstract	Background: Our objective was to identify central line (CL)-associated bloodstream infections (CLABSI) rates and risk factors in Latin-America. Methods: From January 1, 2014 to February 10, 2022, we conducted a multinational multicenter prospective cohort study in 58 ICUs of 34 hospitals in 21 cities in 8 Latin American countries (Argentina, Brazil, Colombia, Costa Rica, Dominican Republic, Ecuador, Mexico, Panama). We applied multiple-logistic regression. Outcomes are shown as adjusted-odds ratios (aOR). Results: About 29,385 patients were hospitalized during 92,956 days, acquired 400 CLABSIs, and pooled CLABSI rate was 4.30 CLABSIs per 1,000 CL-days. We analyzed following 10 variables: Gender, age, length of stay (LOS) before CLABSI acquisition, CL-days before CLABSI acquisition, CL-device utilization (DU) ratio, CL-type, tracheostomy use, hospitalization type, intensive care unit (ICU) type, and facility ownership, Following variables were independently associated with CLABSI: LOS before CLABSI acquisition, rising risk 3% daily (aOR=1.03;95%CI=1.02-1.04; P < .0001); number of CL-days before CLABSI acquisition, rising risk 4% per CL-day (aOR=1.04;95%CI=1.03-1.05; P < .0001); publicly-owned facility (aOR=2.33;95%CI=1.79-3.02; P < .0001). ICU with highest risk was medical-surgical (aOR=2.61;95%CI=1.41-4.81; P < .0001). CL with the highest risk were femoral (aOR=2.71;95%CI=1.61-4.55; P < .0001), and internal-jugular (aOR=2.62;95%CI=1.82-3.79; P < .0001). PICC (aOR=1.25;95%CI=0.63-2.51; P = .52) was not associated with CLABSI risk. Conclusions: Based on these findings it is suggested to focus on reducing LOS, CL-days, using PICC instead of femoral or internal-jugular; and implementing evidence-based CLABSI prevention recommendations.
MeSH term(s)	Humans ; Cross Infection/prevention & control ; Catheter-Related Infections/prevention & control ; Prospective Studies ; Latin America/epidemiology ; Incidence ; Intensive Care Units ; Risk Factors ; Sepsis/epidemiology ; Catheterization, Central Venous/adverse effects
Language	English
Publishing date	2023-03-14
Publishing country	United States
Document type	Multicenter Study ; Journal Article
ZDB-ID	392362-9
ISSN	1527-3296 ; 0196-6553
ISSN (online)	1527-3296
ISSN	0196-6553
DOI	10.1016/j.ajic.2023.03.006
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 1773: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

To top

Full text online

More links

Kategorien

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

Full text online

More links

Kategorien

Order via subito

Kategorien

Inter-library loan at ZB MED

Full text online

More links

Kategorien

Inter-library loan at ZB MED

Kategorien

Inter-library loan at ZB MED

Kategorien

Inter-library loan at ZB MED

Full text online

More links

Kategorien

Inter-library loan at ZB MED

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito